Skip to main content
AVTX logo

AVTX

Avalo Therapeutics Inc

$6.76

0.10%

Trade Ideas Performance

Latest Closed Trade Idea

$6.76

0.10%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

0

Social

43

About

Events of Avalo Therapeutics Inc (AVTX)

Avalo Therapeutics' stock price significantly declined by 57.29% over the year, from $16.67 on November 3, 2025, to $7.12 on October 28, 2026, trading between a 52-week high of $24.27 and a low of $6.53. Key events include a GAAP net loss of $18.9 million in Q3 2026, positive Phase 2 LOTUS data for abdakibart in May 2026, and the pivotal negative event of cendakimab's Phase 2 failure. Upcoming milestones include FDA feedback on abdakibart by year-end 2026, initiation of a Phase 3 program for hidradenitis suppurativa in H1 2027, and an IND submission for AVTX-010 in H1 2027. Analyst ratings saw Stifel lowering its price target to $30 while maintaining Buy, Guggenheim downgrading to Neutral, and H.C. Wainwright and Cantor Fitzgerald reiterating Buy/Overweight ratings.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)